Lifeward Ltd(LFWD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 21 at 4:00 PM ET (Korea 10/22 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -16.79 | Insider Own | 46.22% | Shs Outstand | 2.8M | Perf Week | -11.58% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | 76.32% | Insider Trans | - | Shs Float | 1.5M | Perf Month | -20.75% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | -0.79 | Inst Own | 1.14% | Short Float | 6.35% | Perf Quarter | -21.76% |
| Income | -0.03B | P/S | 0.71 | EPS this Y | 56.92% | Inst Trans | 0.9% | Short Ratio | 16.8 | Perf Half Y | -28.1% |
| Sales | 0.02B | P/B | 1.27 | EPS next 5Y | 65.57% | ROA | -99.81% | Short Interest | 0.10M | Perf YTD | -20.51% |
| Book/sh | 4.32 | P/C | 1.65 | EPS past 3/5Y | 13.32% 24.32% | ROE | -225.65% | 52W High | -42.77% ($9.61) | Perf Year | -32.6% |
| Cash/sh | 3.34 | P/FCF | - | Sales past 3/5Y | 58.72% 38.06% | ROIC | -136.75% | 52W Low | 32.85% ($4.14) | Perf 3Y | -90.15% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 55.33% | Gross Margin | 24.48% | Volatility(W/M) | 4.15% 5.55% | Perf 5Y | -95.19% |
| Dividend TTM | - | EV/Sales | 0.79 | Sales Y/Y TTM | -10.68% | Oper. Margin | -81.79% | ATR (14) | 0.35 | Perf 10Y | -99.95% |
| Dividend Ex-Date | - | Quick Ratio | 1.77 | EPS Q/Q | 41.26% | Profit Margin | -141.28% | RSI (14) | 29.6 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.33 | Sales Q/Q | 15.71% | SMA20 | -12.89% ($6.31) | Beta | 0.55 | Target Price | $20 |
| Payout | - | Debt/Eq | 0.91 | Earnings | 2026/8/14 | SMA50 | -20.15% ($6.89) | Rel Volume | 0.75 | Prev Close | $5.61 |
| Employees | 81 | LT Debt/Eq | 0.85 | EPS/Sales Surpr. | -5.32% 1.41% | SMA200 | -21.72% ($7.03) | Avg Volume(3M) | 0.01M | Price | $5.5 |
| IPO | 2014/9/12 | Option/Short | No/Yes | Trades | 195 | Volume | 4,293 | Change | -1.96% |
A medical device and wearable robotic (exoskeleton) company that helps patients with spinal cord injuries, strokes, and lower-limb paralysis regain gait and undergo rehabilitation training. Its portfolio of "gait and mobility recovery solutions" combines flagship offerings such as the ReWalk® personal exoskeleton, the redesigned ReStore Exo-Suit, the AlterG® anti-gravity treadmill, and the MyoCycle FES (functional electrical stimulation) stationary bike.
Over the past 1 year, on the lower side
43% below its 1-year high.
Traded less than usual. That is 75% of its average volume.
LFWD has a sound balance sheet but weak earning power
Of every $100 in sales, $81.79 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +56.9% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $71. Peers typically go for $148.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -95.2%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 1.1%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #115 of 142 in the industry
Based on market cap of $16M.
FAQ
What kind of company is LFWD?
LFWD belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of LFWD?
The market cap of LFWD is approximately $16M, ranking 5,301 within its sector.
What is the 52-week high and low for LFWD?
LFWD has recorded a 52-week high of $9.61 and a low of $4.14.
